Title |
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
|
---|---|
Published in |
Frontiers in Molecular Neuroscience, September 2018
|
DOI | 10.3389/fnmol.2018.00320 |
Pubmed ID | |
Authors |
Bo-Zong Shao, Qi Cao, Chong Liu |
Abstract |
Central nervous system (CNS) is one of the largest killers of people's health all over the world. The overactivation of the immune and inflammatory responses is considered as an important factor, contributing to the pathogenesis and progression of CNS disorders. Among all kinds of immune and inflammatory reaction, the inflammasome, a complex of proteins, has been drawn increasingly attention to by researchers. The initiation and activation of the inflammasome is involved in the onset of various kinds of diseases. The NLRP3 inflammasome, the most studied member of the inflammasome, is closely associated with many kinds of CNS disorders. Here in this review, the roles of the NLRP3 inflammasome in the pathogenesis and progression of several well-known CNS diseases would be discussed, including cerebrovascular diseases, neurodegenerative diseases, multiple sclerosis, depression as well as other CNS disorders. In addition, several therapeutic strategies targeting on the NLRP3 inflammasome for the treatment of CNS disorders would be described in this review. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 109 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 13% |
Researcher | 13 | 12% |
Student > Bachelor | 13 | 12% |
Student > Master | 12 | 11% |
Other | 6 | 6% |
Other | 11 | 10% |
Unknown | 40 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 16 | 15% |
Biochemistry, Genetics and Molecular Biology | 12 | 11% |
Agricultural and Biological Sciences | 10 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 7% |
Medicine and Dentistry | 6 | 6% |
Other | 12 | 11% |
Unknown | 45 | 41% |